Genetic analysis and clinical features of familial hypokalemic periodic paralysis

ZHANG Hui-li; SUN Yi-ming; ZHENG Min-ying; ZHU Yu-ling; CAO Ji-qing; ZHANG Yu; LI Ya-qin; DENG Lang-hui; ZHANG Cheng
June 2014
Chinese Journal of Contemporary Neurology & Neurosurgery;Jun2014, Vol. 14 Issue 6, p490
Academic Journal
Background To investigate the gene mutation and clinical features of hypokalemic periodic paralysis (HypoPP) in a Han family. Methods Mutation analyses of CACNA1S, SCN4A and KCNE3 gene were screened by DNA direct sequencing in the proband (III3). Then, other patients and one asymptomatic relative were tested for the mutation detected in the proband before. Besides, clinical information was collected and analyzed carefully so as to detect whether the mutations were responsible for HypoPP. Results KCNE3 gene was not detected in the propositus (III 3). Mutations of IVS25-194C/T in CACNA1S gene were detected in the propositus (III 3) and other patients (II 1, III 4, IV 3), while it was not detected in the asymptomatic relative (III1). Given that it was an intron mutation, we presumed that it was not responsible for HypoPP in this family. In addition, mutations of IVS18-130G/A in SCN4A gene were detected in all patients (except for I 1) and asymptomatic relative (III 1). Since it was an intron mutation and it was detected in symptomatic or asymptomatic members simultaneously, we also presumed that it was not responsible for HypoPP in this family. Interestingly, a missense mutation (V662I) of c.1984G > A in exon 12 of SCN4A gene was detected in the proband (III 3) and asymptomatic relative (III 1). However, it was not detected in other symptomatic members ( II 1, III 4, IV 3). Based on clinical information and bioinformatics, we presumed that it was not causative mutation for the disease in this pedigree. Conclusions This pedigree research enriched the data of gene mutation and clinical features of HypoPP in China. Besides for gene KCNE3, CACNA1S and SCN4A, other gene mutations accounted for HypoPP in the Han family should be further studied.


Related Articles

  • Genetics: More than one way.... McCarthy, Nicola // Nature Reviews Cancer;Oct2008, Vol. 8 Issue 10, p742 

    The article presents three studies on the genetic changes in tumor evolution using different systematic approaches. Cancer Genome Atlas project used DNA methylation and coding of RNA expression to identify cancer-causing genomic alterations in glioblastoma patients. Another research utilized...

  • Mutation screening in Börjeson-Forssman-Lehmann syndrome: identification of a novel de novo PHF6 mutation in a female patient. Crawford, J.; Lower, K. M.; Hennekam, R. C. M.; Van Esch, H.; Mégarbané, A.; Lynch, S. A.; Turner, G.; Gécz, J. // Journal of Medical Genetics;Mar2006, Vol. 43 Issue 3, p238 

    Background: Börjeson-Forssman-Lehmann syndrome (BFLS; MIM 301900) is an infrequently described X linked disorder caused by mutations in PHF6, a novel zinc finger gene of unknown function. Objective: To present the results of mutation screening in individuals referred for PHF6 testing and...

  • Genetic screening reveals high frequency of PARK2 mutations and reduced Parkin expression conferring risk for Parkinsonism in North West India. Vinish, Monika; Prabhakar, Sudesh; Khullar, Madhu; Verma, Indu; Anand, Akshay // Journal of Neurology, Neurosurgery & Psychiatry;Feb2010, Vol. 81 Issue 2, p166 

    Background Among several aetiological factors, PARK2 mutations are the most common cause of Parkinson disease (PD) that result in degeneration of dopaminergic neurons in the substantia nigra. Methods In order to examine the contribution of PARK2 mutations and corresponding Parkin expression in...

  • Clinical characteristics and gene mutation analysis of riboflavin - responsive lipid storage myopathy: report of 3 cases in 2 families and review of literature. CAO Ji-qing; ZHANG Cheng; LI Ya-qin; YANG Juan; LIANG Ying-yin; FENG Shan-wei; ZHANG Xu; LI Jing; ZHANG Hui-li; ZHU Yu-ling; GENG Jia; YANG Li-qing // Chinese Journal of Contemporary Neurology & Neurosurgery;Jun2014, Vol. 14 Issue 6, p479 

    Objective The clinical manifestation and electron transfer flavoprotein dehydrogenase (ETFDH) gene mutation of riboflavin-responsive lipid storage myopathy were analyzed for early diagnosis and treatment. Methods Clinical material, ETFDH gene mutation and the motor function before and after...

  • Natural history of Duchenne muscular dystrophy. KE Qing; ZHANG Li // Chinese Journal of Contemporary Neurology & Neurosurgery;May2015, Vol. 15 Issue 5, p355 

    Duchenne muscular dystrophy (DMD) is X-linked recessive hereditary disease. DMD gene mutations result in dystrophin deficiency, which causes not only muscle movement disorders but also scoliosis, cognitive dysfunction, urinary tract diseases, respiratory diseases and heart diseases. Most...

  • Genetic diagnosis and treatment progress of primary periodic paralysis. KE Qing // Chinese Journal of Contemporary Neurology & Neurosurgery;Jun2014, Vol. 14 Issue 6, p471 

    Primary periodic paralysis is autosomal dominant genetic skeletal muscle ion channelopathy. It is characterized by episodes of muscle weakness associated with lower, normal or elevated serum potassium. The genetic diagnosis process of periodic paralysis is proposed based on the latest research...

  • Are we entering a new age of gene tests and designer drugs? Knott, Christine // Biologist;Dec2003, Vol. 50 Issue 6, p247 

    Describes 'pharmacogenetic analyses' which evaluates sequence variations in genes that are suspected of affecting drug responses. Benefits of pharmacogenomics, which seeks to identify genetic basis underlying variable drug responses, to pharmacogenetics; Information on genetic screening; Need...

  • Genetic Testing of Korean Familial Hypercholesterolemia Using Whole-Exome Sequencing. Han, Soo Min; Hwang, Byungjin; Park, Tae-gun; Kim, Do-Il; Rhee, Moo-Yong; Lee, Byoung-Kwon; Ahn, Young Keun; Cho, Byung Ryul; Woo, Jeongtaek; Hur, Seung-Ho; Jeong, Jin-Ok; Park, Sungha; Jang, Yangsoo; Lee, Min Goo; Bang, Duhee; Lee, Ji Hyun; Lee, Sang-Hak // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Familial hypercholesterolemia (FH) is a genetic disorder with an increased risk of early-onset coronary artery disease. Although some clinically diagnosed FH cases are caused by mutations in LDLR, APOB, or PCSK9, mutation detection rates and profiles can vary across ethnic groups. In this study,...

  • Exome Sequencing Identified a Recessive RDH12 Mutation in a Family with Severe Early-Onset Retinitis Pigmentosa. Gong, Bo; Wei, Bo; Huang, Lulin; Hao, Jilong; Li, Xiulan; Yang, Yin; Zhou, Yu; Hao, Fang; Cui, Zhihua; Zhang, Dingding; Wang, Le; Zhang, Houbin // Journal of Ophthalmology;6/1/2015, Vol. 2015, p1 

    Retinitis pigmentosa (RP) is the most important hereditary retinal disease caused by progressive degeneration of the photoreceptor cells. This study is to identify gene mutations responsible for autosomal recessive retinitis pigmentosa (arRP) in a Chinese family using next-generation sequencing...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics